Literature DB >> 9504860

Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver.

R Lichtinghagen1, K Breitenstein, B Arndt, T Kühbacher, K H Böker.   

Abstract

To study the extend of ongoing tissue remodelling in end-stage cirrhosis, the expression of different matrix metalloproteinases [interstitial collagenase (MMP-1), Mr 72000 gelatinase (MMP-2), stromelysin-1 (MMP-3) and stromelysin-3 (MMP-11)] and of TIMP-1 was studied in 13 cirrhotic livers explanted at transplantation. The results were compared with those obtained in normal liver. Western blot, northern blot, ELISA, RT-PCR and zymogram analysis were used. Proenzymes of stromelysin-1 and -3, interstitial collagenase and Mr 72000 gelatinase were positive in normal liver, while activated enzymes were not detectable in western blot analysis. In cirrhosis proenzyme levels of the studied MMPs were reduced to a mean of 60-70%, but mRNA expression and gelatin-degrading activity increased. TIMP-1 expression was detectable on mRNA level and by ELISA in normal liver and also increased in cirrhosis. Our results show that mRNA expression of certain matrix metalloproteinases is increased in end-stage liver cirrhosis, while the amount of proenzyme is decreased, indicating enhanced MMP proenzyme turnover. These data suggest that besides increased TIMP-1 activity, altered MMP expression may also play a part in fibroproliferation in liver disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504860     DOI: 10.1007/s004280050149

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  10 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

2.  Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 expression in fibrotic rat liver.

Authors:  Hai-Lin Liu; Xuan-Hai Li; Dan-Yi Wang; Shao-Ping Yang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

3.  High serum matrix metalloproteinase-3 and liver stiffness in postoperative biliary atresia.

Authors:  Sittisak Honsawek; Kesmanee Praianantathavorn; Voranush Chongsrisawat; Paisarn Vejchapipat; Apiradee Theamboonlers; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2010-12-30       Impact factor: 1.827

4.  Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fibrosis in human Schistosoma japonicum infection.

Authors:  Valeria Fabre; Haiwei Wu; Sunthorn PondTor; Hannah Coutinho; Luz Acosta; Mario Jiz; Remigio Olveda; Ling Cheng; Eric S White; Blanca Jarilla; Stephen T McGarvey; Jennifer F Friedman; Jonathan D Kurtis
Journal:  J Infect Dis       Date:  2011-01-03       Impact factor: 5.226

5.  Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis.

Authors:  Ji-Yao Wang; Jin-Sheng Guo; Chang-Qing Yang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

6.  Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis.

Authors:  Alicja Bauer; Andrzej Habior
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

Review 7.  Is cirrhosis of the liver reversible?

Authors:  Manoj Kumar; S K Sarin
Journal:  Indian J Pediatr       Date:  2007-04       Impact factor: 5.319

8.  Deciphering the ovarian cancer ascites fluid peptidome.

Authors:  Anand Bery; Felix Leung; Christopher R Smith; Eleftherios P Diamandis; Vathany Kulasingam
Journal:  Clin Proteomics       Date:  2014-04-02       Impact factor: 3.988

9.  Tgfb3 and Mmp13 regulated the initiation of liver fibrosis progression as dynamic network biomarkers.

Authors:  Jinsheng Guo; Weixin Liu; Zhiping Zeng; Jie Lin; Xingxin Zhang; Luonan Chen
Journal:  J Cell Mol Med       Date:  2020-12-02       Impact factor: 5.295

10.  Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD rats.

Authors:  Ali Amirinejad; Ali Saneei Totmaj; Farzaneh Mardali; Azita Hekmatdoost; Hadi Emamat; Majid Safa; Farzad Shidfar
Journal:  BMC Complement Med Ther       Date:  2021-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.